GLP-1 Agonists
Sort by:
Houston Methodist DeBakey Heart and Vascular Center
Medical Management of Obesity: The Future Is Bright
FEATURING
Mohamad Taha
- 696 views
- October 20, 2021
- 4
Practical Ways to Achieve Targets in Diabetes Care
Innovation and FDA's Role
FEATURING
Courtney Lias
- 31 views
- November 22, 2021
Practical Ways to Achieve Targets in Diabetes Care
Process for FDA Drug Approval
FEATURING
Mahtab Niyyati
- 13 views
- November 22, 2021
KDIGO
SGLT2 Inhibitors and GLP-1 Receptor Agonists: Different Classes, Different Modes of Kidney Protection
FEATURING
Hiddo Lambers Heerspink
- 542 views
- January 24, 2022
- 6
3rd National Conference On Prevention Of Diabetes
GLP-1 Agonists and Prediabetes
FEATURING
Abraham Thomas
- 306 views
- December 7, 2018
- 1
3rd National Conference On Prevention Of Diabetes
Metformin and Diabetes Prevention
FEATURING
Mahmoud Ibrahim
- 558 views
- December 7, 2018
- 1
Cedars Sinai
New Approaches and Therapies for Weight Management and CVD Risk
FEATURING
Simona Campa
- 219 views
- May 25, 2022
- 3
Canadian Collaborative Research Network
Q&A: Colchicine, Oral GLP-1a and Other Drugs
- 82 views
- June 13, 2022
Canadian Collaborative Research Network
GLP-1 Agonists: Underused and Underappreciated?
FEATURING
Darren K. Mcguire
- 315 views
- June 13, 2022
- 1
Canadian Collaborative Research Network
CV Medicine in the Next Decade: Predicting the Future
FEATURING
Deepak Bhatt
- 363 views
- June 13, 2022
- 2
Scripps Health
Cardiodiabetology: Expanding Your Specialty
FEATURING
Samantha Harris
- 692 views
- June 28, 2022
- 6
Banshi Saboo
Current & Emerging Big Molecules for Obesity: GLP-1 RA (Sema 2.4 mg, Lira 3mg), Tirzepatide, Cagrisema
- 1,273 views
- July 26, 2022
- 4
3rd National Conference On Prevention Of Diabetes
CVD Outcome Trials in T2DM: GLP-1 Receptor Agonists
FEATURING
Peter Gaede
- 266 views
- December 7, 2018
- 1
The Texas Heart Institute
Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire
FEATURING
Stephanie Coulter,
Darren K. Mcguire
- 56 views
- March 10, 2023
- 1
Scripps Health
Obesity and Diabetes Pharmacotherapy: Are You Ready for GLP-1 Agonists?
FEATURING
Samantha Harris
- 1,505 views
- June 21, 2023
- 11
Icahn School of Medicine at Mount Sinai
Medical Management of Obesity
FEATURING
Reshmi Srinath
- 1,011 views
- July 5, 2023
- 7
UC Davis Health Diabetes and Endocrinology Symposium
Mixing and Matching Antidiabetic Medications: What's the Best Combination?
FEATURING
John Yoon
- 1,191 views
- December 6, 2018
- 4
UC Davis Health Diabetes and Endocrinology Symposium
Stepwise Therapy Versus Initial Combination Therapy in Diabetes
FEATURING
John Yoon
- 370 views
- December 6, 2018
- 1
UC Davis Health Diabetes and Endocrinology Symposium
Goals of Diabetes Treatment and Considerations in Selecting Diabetes Medications
FEATURING
John Yoon
- 282 views
- November 8, 2018
ASPC 2018 Congress on CVD Prevention
Comprehensive Approach to Lowering CVD Risk in Diabetics
FEATURING
Yehuda Handelsman
- 778 views
- August 10, 2018
- 6
ASPC 2018 Congress on CVD Prevention
Role of SGLT2/GLP1 Agents in a Preventive Cardiologist’s Practice, a Seminal Transition in DM Management
FEATURING
Mikhail Kosiborod
- 975 views
- August 10, 2018
- 3
Dr. Sharmila Ghimire
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity
FEATURING
Dr. Sharmila Ghimire
- 182 views
- September 13, 2023
- 4